Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (855)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (245)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8503)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Aaltonen K
JSON
CSV
XLSX
TXT
Family name
Aaltonen
Given name
Kristina
Initials
K
ORCID
ORCID
0000-0001-5104-735X
Affiliations
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, 223 81 Lund, Sweden.
4 publications
PubMed
DOI
Crossref
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma.
Karlsson J
, Yasui H,
Mañas A
, ...,
Bexell D
,
Gisselsson D
Nat Commun
15
(1) 8992 [2024-10-18; online 2024-10-18]
Clinical Genomics Lund [Service]
PubMed
DOI
Crossref
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance.
Mañas A
,
Aaltonen K
,
Andersson N
, ..., Gisselsson D,
Bexell D
Sci Adv
8
(43) eabq4617 [2022-10-28; online 2022-10-28]
Clinical Genomics Lund [Service]
PubMed
DOI
Crossref
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.
Grigoryan A
,
Zacharaki D
,
Balhuizen A
, ...,
Bexell D
,
Bourgine PE
Sci Transl Med
14
(666) eabm6391 [2022-10-12; online 2022-10-12]
Clinical Genomics Lund [Service]
PubMed
DOI
Crossref
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma.
Hansson K
,
Radke K
,
Aaltonen K
, ..., Gisselsson D,
Bexell D
Sci Transl Med
12
(562) - [2020-09-23; online 2020-09-25]
Clinical Genomics Lund [Service]
SciLifeLab Data Centre
Publications
9.5.1